Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 14 September

Grady Wulff
September 14, 2022

Closing Bell 13 September

Grady Wulff
September 13, 2022

Morning Bell 13 September

Paulina Peters
September 13, 2022

Closing Bell 12 September

Grady Wulff
September 12, 2022

Morning Bell 12 September

Grady Wulff
September 12, 2022

Weekly Wrap 9 September

Grady Wulff
September 9, 2022

Morning Bell 9 September

Sophia Mavridis
September 9, 2022

Closing Bell 8 September

Grady Wulff
September 8, 2022

Morning Bell 8 September

Grady Wulff
September 8, 2022

Closing Bell 7 September

Grady Wulff
September 7, 2022

Morning Bell 7 September

Sophia Mavridis
September 7, 2022

Closing Bell 6 September

Paulina Peters
September 6, 2022